Updates

Get Alerts
September 18, 2024 | PPP Updates
Long-Acting Growth Hormone Products for the Treatment of Growth Hormone Deficiency
Christina M. Polomoff, PharmD, BCACP, BCPS, FASCP, Devra K. Dang, PharmD, BCPS, CDCES, FNAP, Judy T. Chen, PharmD, BCPS, BCACP, CDCES, FNAP
July 24, 2024 | PPP Updates
Update to Guidelines for Nutrition Support in Adult Critically Ill Patients from the American Society for Parenteral and Enteral Nutrition
Sarah J. Miller, PharmD, BCNSP, FASPEN, Professor Emeritus, Sarah S. Nordbeck, PharmD, BCNSP, Nutrition/General Surgery Clinical Pharmacist-Specialist
July 10, 2024 | PPP Updates
Capivasertib Approved in Combination with Fulvestrant for Hormone Receptor Positive Metastatic Breast Cancer with One or More PIK3CA/AKT1/PTEN Alterations
Jill M. Kolesar, PharmD, MS, College of Pharmacy
June 28, 2024 | PPP Updates
New First-Line Role for SGLT2 Inhibitors and Updates across the Spectrum of Heart Failure by Left Ventricular Ejection Fraction
Tien M. H. Ng, Pharm.D., FHFSA, FACC, FCCP, BCPS, Professor of Clinical Pharmacy and Medicine, Samantha L. Yeung, PharmD, MS, BCCP, Assistant Professor of Clinical Pharmacy
June 28, 2024 | PPP Updates
Pivmecillinam: A Newly Approved Penicillin Antibiotic
Julia Keating, PharmD Candidate, Madeline Lemmon, PharmD Candidate, R. Jake Crocker, PharmD, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
June 20, 2024 | PPP Updates
Stable Ischemic Heart Disease: A Focus on Novel Therapies for Lipid Management
Sara Salama, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Dejan Landup, PharmD, HF-Cert, Cardiovascular Clinical Pharmacist
June 20, 2024 | PPP Updates
Ceftobiprole: A Newly Approved Cephalosporin Antibiotic
Caleb Gosnell, PharmD Candidate, Kendall R. Kerr, PharmD Candidate, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
May 6, 2024 | PPP Updates
Ozanimod: A Newly Approved Treatment for Moderate to Severe Ulcerative Colitis
Shubha Bhat, PharmD, MS, FCCP, BCACP Clinical Pharmacy Specialist—Gastroenterology
May 6, 2024 | PPP Updates
Daprodustat—2023 FDA Novel Drug for Anemia Caused by Chronic Kidney Disease
Matthew Sherman, PharmD, MBA, BCMAS, Austin Mondloch, PharmD, MA, BCMAS, Genevieve Lynn Ness Engle, PharmD, BCMAS
May 6, 2024 | PPP Updates
New Precision Therapy for Patients with Cystic Fibrosis
Kimberly J. Novak, PharmD, BCPS, BCPPS, FPPA
May 6, 2024 | PPP Updates
GOLD Guidelines Treatment Updates
Jon P. Wietholter, PharmD, BCPS, FCCP
May 6, 2024 | PPP Updates
Zuranolone (Zurzuvae): The First Oral Agent Approved for the Treatment of Postpartum Depression
Neel Swamy, PharmD, MPH, Kelly C. Lee, PharmD, MAS, BCPP
May 6, 2024 | PPP Updates
Risperidone Extended-Release Injectable Suspension (Uzedy): A New Second-Generation Long-Acting Antipsychotic Formulation of Risperidone Approved for Treatment of Schizophrenia
Viktoriya Titova, PharmD, BCPP
December 27, 2023 | PPP Updates
Reacting to the Rise of Respiratory Syncytial Virus: An Update on Prevention
Megan M. Nguyen, PharmD Candidate of 2024, Amro Assaidi, PharmD Candidate of 2024, Emily M. Scopelliti, PharmD, BCPS, Nicole C. Cheung, PharmD, BCPS
December 27, 2023 | PPP Updates
Quizartinib Approved for FLT3 Internal Tandem Duplication Positive Acute Myeloid Leukemia
Jill M. Kolesar, PharmD, MS
December 27, 2023 | PPP Updates
Lecanemab-irmb (LEQEMBI®): The first FDA-approved monoclonal antibody for Alzheimer's Disease
Munachimso Okoli, PharmD Candidate, Tamia Martin, PharmD Candidate, Soheyla Mahdavian, PharmD, BCGP Professor, Pharmacy Practice
December 12, 2023 | PPP Updates
Abilify Asimtufii®: A Newly Approved Bimonthly Long Acting Injectable
Heeyoung Kim, PharmD Candidate of 2024, Alyssia Calhoun, PharmD Candidate of 2024, Soheyla Mahdavian, PharmD, BCGP, TTS Professor, Pharmacy Practice, Nicole Cheung, PharmD, BCPS Assistant Professor, Science Education
December 12, 2023 | PPP Updates
Updates in Weight Management Pharmacotherapy for Diabetes and Cardiovascular Risk Management
Jennifer J. Stanislaw, PharmD, BCACP
September 27, 2023 | PPP Updates
Spesolimab-sbzo for the management of generalized pustular psoriasis flares
Jenna Mills, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Suzanne Surowiec, PharmD, BCACP, Associate Professor of Teaching in Pharmacy Practice, Celeste VanAtta, PharmD, BCPS, Assistant Professor of Pharmacy Practice
September 27, 2023 | PPP Updates
New data evaluating the role of aspirin for the prevention of venous thromboembolism
Megan C. Herink, PharmD, MBA, BCPS, Clinical Associate Professor
August 21, 2023 | PPP Updates
Ending the HIV epidemic through preventative measures
Daniel Rogers, PharmD, Daniel B. Chastain, PharmD, BCIDP, AAHIVP
August 16, 2023 | PPP Updates
Surviving Sepsis and Antimicrobial Stewardship in the Emergency Department
Kelly Betts, PharmD, Carolina Woloszyn, PharmD, Madeline Belk, PharmD
August 1, 2023 | PPP Updates
New Fecal Microbiota Products for the Prevention of Recurrent Clostridioides difficile Infection
Victoria Madonia, Johny Nguyen, P. Brandon Bookstaver, PharmD, BCIDP, FCCP, FIDSA
August 1, 2023 | PPP Updates
Donepezil Transdermal System (Adlarity®): The First Once-Weekly Patch Approved for Treatment of Mild, Moderate, and Severe Alzheimer’s Dementia
Mary Ngo, PharmD
July 26, 2023 | PPP Updates
2023 Update to the AGS Beers Criteria®
Jeannie K. Lee, PharmD, BCPS, BCGP, FASHP, AGSF, Associate Professor of Department of Pharmacy Practice & Science and Assistant Dean for Student Services